Ultrasonography of the lymph nodes can detect disease recurrence and help predict the development of distant metastases in women who have had surgery for breast cancer, according to a study in the September issue of Radiology.
Ultrasonography of the lymph nodes can detect disease recurrence and help predict the development of distant metastases in women who have had surgery for breast cancer, according to a study in the September issue of Radiology.
Hee Jung Moon, MD, of Yonsei University College of Medicine in Seoul, South Korea, and colleagues performed ultrasonography imaging on the lymph nodes of 1,817 women who had undergone breast surgery. The ultrasonography imaging was evaluated for detection of lymph node recurrence (LNR). The incidence of distant metastases in patients with ipsilateral LNR was compared to the incidence of metastases without LNR.
In at least 12 months of follow-up, the researchers found that 39 of the patients had LNR, of whom 11 had ipsilateral LNR only. For detecting LNR, ultrasonography had a sensitivity of 76.9%, specificity of 98.7%, accuracy of 98.2%, positive predictive value of 55.6%, and negative predictive value of 99.5%. Distant metastases occurred more in patients with ipsilateral LNR (62%) than in those without (2.3%).
“On the basis of our study findings, ipsilateral axillary or supraclavicular LNR was a useful predictor of concurrent or subsequent distant metastasis. Thus, imaging surveillance for distant metastases should be performed in patients with ipsilateral LNR. Lymph node ultrasonography of the bilateral axillary and supraclavicular lymph node areas is useful for early detection of ipsilateral and contralateral LNR in the absence of symptoms,” the authors write.
Moon HJ, Kim MJ, Kim EK, et al. US surveillance of regional lymph node recurrence after breast cancer surgery. Radiology. 2009;252:673-681.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More